#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1106174	B	Inhibition of Acinetobacter baumannii beta-lactamase OXA40	Acinetobacter baumannii	1	ALA1156997	single protein format	Scientific Literature
2.	ALA1799222	B	Inhibition of Acinetobacter baumannii beta lactamase OXA-40	Acinetobacter baumannii	10	ALA1795309	single protein format	Scientific Literature
3.	ALA3117137	B	Inhibition of beta-lactamase Oxa40 in Acinetobacter baumannii assessed as inhibition of hydrolysis of nitrocefin	Acinetobacter baumannii	18	ALA3112543	single protein format	Scientific Literature
4.	ALA3882467	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
5.	ALA3882468	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
6.	ALA3882470	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13304 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
7.	ALA3882471	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13304 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
8.	ALA3882473	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13305 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
9.	ALA3882474	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13305 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
10.	ALA3882476	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-3 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
11.	ALA3882477	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-3 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
12.	ALA3882479	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-4 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
13.	ALA3882480	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-4 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
14.	ALA3882482	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
15.	ALA3882483	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
16.	ALA3882485	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
17.	ALA3882486	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
18.	ALA3882488	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 to 8 ug/ml incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	2	ALA3882388	single protein format	Patent Bioactivity Data
19.	ALA3882489	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as reduction in bacterial growth coadministered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data
20.	ALA3882490	B	Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii NCTC 13301 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 4 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method	Acinetobacter baumannii	1	ALA3882388	single protein format	Patent Bioactivity Data